Fig. 2

DAPSA LDA^a and MDA^b responses with IXE with or without concomitant MTX after 52 weeks of treatment. ^aDAPSA LDA requires DAPSA score ≤ 14. ^bMDA criteria requires improvement in ≥ 5 of 7 domains (TJC ≤ 1, SJC ≤ 1, PASI ≤ 1 or percentage of BSA affected ≤ 3, patient’s assessment of pain VAS ≤ 15, patient’s global assessment of disease activity VAS ≤ 20, HAQ-DI ≤ 0.5, and tender entheseal points ≤ 1